3D-QSAR studies of JNK1 inhibitors utilizing various alignment methods

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• JNK1 inhibitors are crucial for treating various diseases.
• Anilinopyrimidine derivatives show promise as JNK1 inhibitors.
• Understanding structure-activity relationships is key to optimizing drug candidates.

Purpose of the Study:

• To perform three-dimensional quantitative structure-activity relationship (3D-QSAR) studies on anilinopyrimidine derivatives targeting JNK1.
• To develop predictive models for JNK1 inhibitor activity using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA).
• To identify key structural features that enhance the inhibitory activity of these compounds.

Main Methods:

• Applied CoMFA and CoMSIA with various alignment strategies, including ligand-based and pharmacophore-based methods.
• Utilized receptor-guided alignment and molecular dynamics simulations to validate models.
• Conducted virtual screening against the NCI database to identify potential novel inhibitors.

Main Results:

• Ligand-based alignment yielded optimal CoMFA models (q(2)=0.646, r(2)=0.983).
• Pharmacophore-based alignment provided good predictive models for both CoMFA (q(2)=0.568, r(2)=0.938) and CoMSIA (q(2)=0.670, r(2)=0.982).
• CoMFA and CoMSIA contour maps highlighted the importance of electropositive groups on the phenyl ring and hydrophobic groups on the pyrimidine ring for enhanced activity.

Conclusions:

• The developed 3D-QSAR models accurately predict the activity of anilinopyrimidine JNK1 inhibitors.
• Structural modifications, specifically adding electropositive and hydrophobic groups, can significantly enhance JNK1 inhibitory potency.
• The findings facilitate the rational design of novel, selective, and potent JNK1 inhibitors for therapeutic applications.